Eloxx Pharmaceuticals Inc (OTC Pink - Current Information:ELOX)
| 1.07 Delayed Data As of Nov 29 |  -0.02 / -1.83%Today’s Change | 0.95 Today|||52-Week Range 10.90 | -41.21% Year-to-Date |
Latest ELOX News | Press Releases
No recent news for Eloxx Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.09 |
| Today’s open | 1.10 |
| Day’s range | 1.05 - 1.12 |
| Volume | 31,764 |
| Average volume (3 months) | 47,193 |
| Market cap | $3.6M |
Data as of 11/29/2023
Growth & Valuation
| Earnings growth (last year) | +56.36% |
| Earnings growth (this year) | +57.06% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACETAdicet Bio Inc | +0.02 | +1.80% |
| SLDBSolid Biosciences In... | -0.11 | -3.90% |
| CUECue Biopharma Inc | -0.07 | -3.04% |
| IFRXInflaRx NV | -0.12 | -8.76% |
Data as of 3:59pm ET, 11/29/2023
Financials
| Next reporting date | March 7, 2024 |
| EPS forecast (this quarter) | -$1.65 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$36.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
Chart unavailable
